Evidence map›Paper›PMID 28922615›Full record

ReviewJournal of dental research2018

The Impact of Incorporating Antimicrobials into Implant Surfaces.

N J Hickok, I M Shapiro, A F Chen

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of dental research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 56 citations in OpenAlex.

  1. The Japanese dental science review · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Biomimetic Coatings in Implant Dentistry: A Quick Update.Journal of functional biomaterials · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic Identification of Methicillin-ResistantInternational journal of microbiology · 2023
    Article
  14. Review
  15. Why Is Tantalum Less Susceptible to Bacterial Infection?Journal of functional biomaterials · 2022
    Article
  16. Article
  17. [Chlorhexidine-grafted phenolamine coating to improve antibacterial property of the titanium surface].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

N J Hickok1 Department of Orthopaedic Surgery, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
I M Shapiro1 Department of Orthopaedic Surgery, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
A F Chen1 Department of Orthopaedic Surgery, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Thomas Jefferson University · USRothman Institute · US

Funding

Training in Tissue Engineering and Regenerative MedicineT32AR052273 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI SHAPIRO, IRVING M · 2006 to 2020
$3.3M
Preventing Spinal Infection: Ultrasound Triggered ProphylaxisR01AR069119 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI Flemming Forsberg, Noreen J Hickok · 2016 to 2026
$3.2M
Smart Substrates for a New Generation of ImplantsR01AR051303 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI SHAPIRO, IRVING M · 2005 to 2009
$3.1M
Synovial Fluid and Joint SepsisR01AR072513 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI HICKOK, NOREEN J · 2017 to 2021
$2.5M
Creating an Infection-Free Intraosseus Transcutaneous Amputation ProsthesisR01HD061053 · NICHD · THOMAS JEFFERSON UNIVERSITY · PI ADAMS, CHRISTOPHER S, HICKOK, NOREEN J · 2009 to 2012
$1.3M
A new allograft that promotes long-term, infection-free skeletal repairR01DE019901 · NIDCR · THOMAS JEFFERSON UNIVERSITY · PI ADAMS, CHRISTOPHER S, HICKOK, NOREEN J · 2009 to 2010
$875k
NIAMS NIH HHS R01 AR051303NIAMS NIH HHS R01 AR069119NIAMS NIH HHS R01 AR072513NIAMS NIH HHS T32 AR052273NICHD NIH HHS R01 HD061053NIDCR NIH HHS R01 DE019901
6 · The paper itself

Abstract

With the increase in numbers of joint replacements, spinal surgeries, and dental implantations, there is an urgent need to combat implant-associated infection. In addition to stringent sterile techniques, an efficacious way to prevent this destructive complication is to create new implants with antimicrobial properties. Specifically, these implants must be active in the dental implant environment where the implant is bathed in the glycoprotein-rich salivary fluids that enhance bacterial adhesion, and propagation, and biofilm formation. However, in designing an antimicrobial surface, a balance must be struck between antimicrobial activity and the need for the implant to interact with the bone environment. Three types of surfaces have been designed to combat biofilm formation, while attempting to maintain osseous interactions: 1) structured surfaces where topography, usually at the nanoscale, decreases bacterial adhesion sufficiently to retard establishment of infection; 2) surfaces that actively elute antimicrobials to avert bacterial adhesion and promote killing; and 3) surfaces containing permanently bonded agents that generate antimicrobial surfaces that prevent long-term bacterial adhesion. Both topographical and elution surfaces exhibit varying, albeit limited, antimicrobial activity in vitro. With respect to covalent coupling, we present studies on the ability of the permanent antimicrobial surfaces to kill organisms while fostering osseointegration. All approaches have significant drawbacks with respect to stability and efficacy, but the permanent surfaces may have an edge in creating a long-term antibacterial environment.

Indexed as

Dental ImplantsAnti-Infective AgentsBacterial AdhesionBiofilmsDental Implantation, EndosseousHumansOsseointegrationAnti-Infective AgentsDental Implantsantibacterial surfacesantibioticsbiofilmdental implantsimplant-associated infectionosseointegration

Identifiers

PMID28922615
PMCPMC5755811
OpenAlexW2754203858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.